Biologic agents in COPD management
Rev Mal Respir. 2023 Dec 20:S0761-8425(23)00291-7. doi: 10.1016/j.rmr.2023.11.003. Online ahead of print.ABSTRACTChronic obstructive pulmonary disease (COPD) is a frequently occurring disease entailing high morbidity and mortality, and relevant therapeutic resources are limited. As is the case with asthma, the current trend consists in the phenotyping of COPD patients so as to develop personalized medicine tailored to a given individual's inflammatory profile. The aim of this review is to summarize the role of biologic agents in the management of COPD, taking into consideration not only COPD pathophysiology, but also the p...
Source: Revue des Maladies Respiratoires - December 21, 2023 Category: Respiratory Medicine Authors: M Gue çamburu M Zysman Source Type: research
The contribution of artificial intelligence (AI) subsequent to the processing of thoracic imaging
Rev Mal Respir. 2023 Dec 20:S0761-8425(23)00290-5. doi: 10.1016/j.rmr.2023.12.001. Online ahead of print.ABSTRACTThe contribution of artificial intelligence (AI) to medical imaging is currently the object of widespread experimentation. The development of deep learning (DL) methods, particularly convolution neural networks (CNNs), has led to performance gains often superior to those achieved by conventional methods such as machine learning. Radiomics is an approach aimed at extracting quantitative data not accessible to the human eye from images expressing a disease. The data subsequently feed machine learning models and pr...
Source: Revue des Maladies Respiratoires - December 21, 2023 Category: Respiratory Medicine Authors: P A Grenier A L Brun F Mellot Source Type: research
Biologic agents in COPD management
Rev Mal Respir. 2023 Dec 20:S0761-8425(23)00291-7. doi: 10.1016/j.rmr.2023.11.003. Online ahead of print.ABSTRACTChronic obstructive pulmonary disease (COPD) is a frequently occurring disease entailing high morbidity and mortality, and relevant therapeutic resources are limited. As is the case with asthma, the current trend consists in the phenotyping of COPD patients so as to develop personalized medicine tailored to a given individual's inflammatory profile. The aim of this review is to summarize the role of biologic agents in the management of COPD, taking into consideration not only COPD pathophysiology, but also the p...
Source: Revue des Maladies Respiratoires - December 21, 2023 Category: Respiratory Medicine Authors: M Gue çamburu M Zysman Source Type: research
The contribution of artificial intelligence (AI) subsequent to the processing of thoracic imaging
Rev Mal Respir. 2023 Dec 20:S0761-8425(23)00290-5. doi: 10.1016/j.rmr.2023.12.001. Online ahead of print.ABSTRACTThe contribution of artificial intelligence (AI) to medical imaging is currently the object of widespread experimentation. The development of deep learning (DL) methods, particularly convolution neural networks (CNNs), has led to performance gains often superior to those achieved by conventional methods such as machine learning. Radiomics is an approach aimed at extracting quantitative data not accessible to the human eye from images expressing a disease. The data subsequently feed machine learning models and pr...
Source: Revue des Maladies Respiratoires - December 21, 2023 Category: Respiratory Medicine Authors: P A Grenier A L Brun F Mellot Source Type: research
Biologic agents in COPD management
Rev Mal Respir. 2023 Dec 20:S0761-8425(23)00291-7. doi: 10.1016/j.rmr.2023.11.003. Online ahead of print.ABSTRACTChronic obstructive pulmonary disease (COPD) is a frequently occurring disease entailing high morbidity and mortality, and relevant therapeutic resources are limited. As is the case with asthma, the current trend consists in the phenotyping of COPD patients so as to develop personalized medicine tailored to a given individual's inflammatory profile. The aim of this review is to summarize the role of biologic agents in the management of COPD, taking into consideration not only COPD pathophysiology, but also the p...
Source: Revue des Maladies Respiratoires - December 21, 2023 Category: Respiratory Medicine Authors: M Gue çamburu M Zysman Source Type: research
The contribution of artificial intelligence (AI) subsequent to the processing of thoracic imaging
Rev Mal Respir. 2023 Dec 20:S0761-8425(23)00290-5. doi: 10.1016/j.rmr.2023.12.001. Online ahead of print.ABSTRACTThe contribution of artificial intelligence (AI) to medical imaging is currently the object of widespread experimentation. The development of deep learning (DL) methods, particularly convolution neural networks (CNNs), has led to performance gains often superior to those achieved by conventional methods such as machine learning. Radiomics is an approach aimed at extracting quantitative data not accessible to the human eye from images expressing a disease. The data subsequently feed machine learning models and pr...
Source: Revue des Maladies Respiratoires - December 21, 2023 Category: Respiratory Medicine Authors: P A Grenier A L Brun F Mellot Source Type: research
Biologic agents in COPD management
Rev Mal Respir. 2023 Dec 20:S0761-8425(23)00291-7. doi: 10.1016/j.rmr.2023.11.003. Online ahead of print.ABSTRACTChronic obstructive pulmonary disease (COPD) is a frequently occurring disease entailing high morbidity and mortality, and relevant therapeutic resources are limited. As is the case with asthma, the current trend consists in the phenotyping of COPD patients so as to develop personalized medicine tailored to a given individual's inflammatory profile. The aim of this review is to summarize the role of biologic agents in the management of COPD, taking into consideration not only COPD pathophysiology, but also the p...
Source: Revue des Maladies Respiratoires - December 21, 2023 Category: Respiratory Medicine Authors: M Gue çamburu M Zysman Source Type: research
The contribution of artificial intelligence (AI) subsequent to the processing of thoracic imaging
Rev Mal Respir. 2023 Dec 20:S0761-8425(23)00290-5. doi: 10.1016/j.rmr.2023.12.001. Online ahead of print.ABSTRACTThe contribution of artificial intelligence (AI) to medical imaging is currently the object of widespread experimentation. The development of deep learning (DL) methods, particularly convolution neural networks (CNNs), has led to performance gains often superior to those achieved by conventional methods such as machine learning. Radiomics is an approach aimed at extracting quantitative data not accessible to the human eye from images expressing a disease. The data subsequently feed machine learning models and pr...
Source: Revue des Maladies Respiratoires - December 21, 2023 Category: Respiratory Medicine Authors: P A Grenier A L Brun F Mellot Source Type: research
Biologic agents in COPD management
Rev Mal Respir. 2023 Dec 20:S0761-8425(23)00291-7. doi: 10.1016/j.rmr.2023.11.003. Online ahead of print.ABSTRACTChronic obstructive pulmonary disease (COPD) is a frequently occurring disease entailing high morbidity and mortality, and relevant therapeutic resources are limited. As is the case with asthma, the current trend consists in the phenotyping of COPD patients so as to develop personalized medicine tailored to a given individual's inflammatory profile. The aim of this review is to summarize the role of biologic agents in the management of COPD, taking into consideration not only COPD pathophysiology, but also the p...
Source: Revue des Maladies Respiratoires - December 21, 2023 Category: Respiratory Medicine Authors: M Gue çamburu M Zysman Source Type: research
The contribution of artificial intelligence (AI) subsequent to the processing of thoracic imaging
Rev Mal Respir. 2023 Dec 20:S0761-8425(23)00290-5. doi: 10.1016/j.rmr.2023.12.001. Online ahead of print.ABSTRACTThe contribution of artificial intelligence (AI) to medical imaging is currently the object of widespread experimentation. The development of deep learning (DL) methods, particularly convolution neural networks (CNNs), has led to performance gains often superior to those achieved by conventional methods such as machine learning. Radiomics is an approach aimed at extracting quantitative data not accessible to the human eye from images expressing a disease. The data subsequently feed machine learning models and pr...
Source: Revue des Maladies Respiratoires - December 21, 2023 Category: Respiratory Medicine Authors: P A Grenier A L Brun F Mellot Source Type: research
